Clinical Trial Update: Ad-HGF Treatment for Myocardial Infarction [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/Phase 2 trial evaluating Ad-HGF therapy for myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Ad-HGF

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Myocardial Infarction | Phase 1, Phase 2 | Status: UNKNOWN